Zwirner, J.; Anders, S.; Bohnert, S.; Burkhardt, R.; Da Broi, U.; Hammer, N.; Pohlers, D.; Tse, R.; Ondruschka, B.
Screening for Fatal Traumatic Brain Injuries in Cerebrospinal Fluid Using Blood-Validated CK and CK–MB Immunoassays. Biomolecules 2021, 11, 1061.
https://doi.org/10.3390/biom11071061
AMA Style
Zwirner J, Anders S, Bohnert S, Burkhardt R, Da Broi U, Hammer N, Pohlers D, Tse R, Ondruschka B.
Screening for Fatal Traumatic Brain Injuries in Cerebrospinal Fluid Using Blood-Validated CK and CK–MB Immunoassays. Biomolecules. 2021; 11(7):1061.
https://doi.org/10.3390/biom11071061
Chicago/Turabian Style
Zwirner, Johann, Sven Anders, Simone Bohnert, Ralph Burkhardt, Ugo Da Broi, Niels Hammer, Dirk Pohlers, Rexson Tse, and Benjamin Ondruschka.
2021. "Screening for Fatal Traumatic Brain Injuries in Cerebrospinal Fluid Using Blood-Validated CK and CK–MB Immunoassays" Biomolecules 11, no. 7: 1061.
https://doi.org/10.3390/biom11071061
APA Style
Zwirner, J., Anders, S., Bohnert, S., Burkhardt, R., Da Broi, U., Hammer, N., Pohlers, D., Tse, R., & Ondruschka, B.
(2021). Screening for Fatal Traumatic Brain Injuries in Cerebrospinal Fluid Using Blood-Validated CK and CK–MB Immunoassays. Biomolecules, 11(7), 1061.
https://doi.org/10.3390/biom11071061